Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer
Open Access
- 28 January 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (4), 987-993
- https://doi.org/10.1038/sj.onc.1202371
Abstract
Twelve Barrett's adenocarcinomas have been analysed for the occurrence of allelic imbalance (LOH) on chromosome 17 using 41 microsatellite markers. This study provides evidence for 13 minimal regions of LOH, six on 17p and seven on 17q. Four of these centre in the vicinity of the known tumour suppressor genes (TSGs) TP53 (17p13.1), NF1 (17q11.2), BRCA1 (17q21.1), and a putative TSG (17p13.3). The tumours all displayed relatively small regions of LOH (1 – 10 cM), and in several tumours extensive regions of LOH were detected. One tumour displayed only two very small regions of LOH; 17p11.2 and 17p13.1. The frequency of allelic imbalance has been calculated based on the LOH encompassing only one minimal region, and based on all the LOH observations. By both evaluations the highest LOH frequencies were found for regions II (p53), III (17p13.1 centromeric to p53), IV (17p12), V (17p11.2) and VII (NF1, 17q11.2). Our data supports the existence of multiple TSGs on chromosome 17 and challenges the view that p53 is the sole target of LOH on 17p in Barrett's adenocarcinoma.Keywords
This publication has 33 references indexed in Scilit:
- Localization of prostate cancer metastasis-suppressor activity on human chromosome 17The Prostate, 1997
- Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25Oncogene, 1997
- Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regionsOncogene, 1997
- p53 correlates with improved survival in patients with esophageal adenocarcinomaJournal of Surgical Oncology, 1995
- Tylosis oesophageal cancer mappedNature Genetics, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Barrett's oesophagus—cancer risk, biology and therapeutic managementAlimentary Pharmacology & Therapeutics, 1993
- Barrett's esophagus: Pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical managementDysphagia, 1993
- NF1: a prevalent cause of tumorigenesis in human cancers?Nature Genetics, 1993
- Chromosome 17p loss in carcinoma of the cervix uteriCancer Genetics and Cytogenetics, 1989